“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, Stryker. "With dedicated resources and a focused strategy, the business will be well positioned to succeed as part of Viscogliosi Brothers.”

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to divest its international enterprises in the months to come. | Stryker is selling off its spine implant business—starting with a plan to spin off its U.

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its outlook for 2025.

PORTAGE, Michigan - Medical (TASE:PMCN) technology company Stryker (NYSE:SYK), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $151 billion and annual revenue of $22 billion,

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space,